- Global Market News
- Posts
- Costco to offer deep discounts on Ozempic, Wegovy for members without insurance
Costco to offer deep discounts on Ozempic, Wegovy for members without insurance
GLP-1 drugs, crypto, AI, and stealth tech plays are all seeing major money flows—here’s what investors are clicking on first.
Thank you for being a Global Market News Subscriber!
A membership perk just became a market story. Costco’s move into discounted GLP-1 prescriptions is rattling pharma, healthcare, and insurance models—and it’s not the only surprise investors are reacting to today.
Top Stories of the Day:
🏪
Costco Is Now Selling Ozempic and Wegovy at a Huge Discount
GLP-1 weight-loss drugs just went retail. Costco’s partnership with Novo Nordisk could upend pharmacy pricing, reshape insurance dynamics, and supercharge demand for the most-hyped drugs in America.
💡Sponsor Spotlight
FDA Approval Could Send this Stock Soaring
Whenever the FDA approves a new drug...
Timely investors could see 300-400% returns...
ChemoCentryx soared 281% in the year after it won FDA approval...
Immunogen jumped 449% in the two years after it won FDA approval...
Even Krystal Biotech rose 242% when it looked like it would win FDA approval, which it did.
💰
Shutdown Fuels Crypto Rally: Bitcoin and Gold Are Winning the Safe-Haven Trade
Bitcoin and gold are ripping as Washington edges toward another shutdown. Investors aren’t waiting for the fallout—they’re already rotating into hard assets.
📈
The “Poor Man’s AI Play” That Wall Street Is Quietly Snapping Up
Forget chasing Nvidia at the top. This behind-the-scenes AI enabler is getting institutional attention—without the hype premium.
💡Sponsor Spotlight
Here's the Best Day to Buy Stocks
Did you know the S&P 500 has a 100% history of soaring, beginning on one particular day every fall?
We call this the "Green Day phenomenon." It works on 5,000 stocks.
For example, Nvidia has a 100% history of soaring beginning on one particular day every single year.
🔥
AMD and OpenAI Just Teamed Up—Here’s Why Investors Should Pay Attention
A new AI chip alliance is taking aim at Nvidia’s lead. This deal signals where the next leg of the AI buildout is headed—and who stands to profit.
Want to advertise in Global Market News?
If your company is interested in reaching an audience of engaged and informed investors.👉 Click here to learn more
Know what you own, and know why you own it.
-Peter Lynch
You are receiving this email because you opted in to receive updates from Global Market News. This newsletter may contain sponsored content or advertisements. Information provided is for informational purposes only and should not be considered financial or investment advice. Always consult a financial advisor before making investment decisions.